share_log

和鉑醫藥-B：截至二零二四年四月三十日止之股份發行人的證券變動月報表

HBM HOLDINGS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

Hong Kong Stock Exchange ·  May 7 18:42
Summary by Futu AI
和鉑醫藥控股有限公司（和铂医药-B）於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年4月30日的公司股份變動情況。報告顯示，公司的法定/註冊股本維持在20,000,000,000股，每股面值0.000025美元，總股本為500,000美元，本月未有增減。此外，公司的股份期權計劃中，上月底結存的股份期權數目為39,250,950，本月內無變動，結存數目維持不變。股份獎勵計劃下，本月內發行了1,811,500新股份，本月底可能發行的新股份數目為2,187,250。公司亦於2024年4月30日購回了1,750,000股份。綜合本月內所有股份變動，公司普通股增加／減少總額為61,500股。報告最後確認，所有證券發行均已獲得董事會授權，並符合相關法律規定。
和鉑醫藥控股有限公司（和铂医药-B）於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年4月30日的公司股份變動情況。報告顯示，公司的法定/註冊股本維持在20,000,000,000股，每股面值0.000025美元，總股本為500,000美元，本月未有增減。此外，公司的股份期權計劃中，上月底結存的股份期權數目為39,250,950，本月內無變動，結存數目維持不變。股份獎勵計劃下，本月內發行了1,811,500新股份，本月底可能發行的新股份數目為2,187,250。公司亦於2024年4月30日購回了1,750,000股份。綜合本月內所有股份變動，公司普通股增加／減少總額為61,500股。報告最後確認，所有證券發行均已獲得董事會授權，並符合相關法律規定。
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTH CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 7 MAY 2024, REPORTING THE CHANGES IN THE COMPANY'S SHARES FOR THE YEAR ENDED 30 APRIL 2024. The report showed that the company's regulated/registered share capital remained at 20,000,000,000 shares with a face value of $0.000025 per share and a total share capital of $500,000, with no increase this month. In addition, the number of stock options outstanding at the end of last month was 39,250,950 in the Company's stock option program, which remained unchanged during the month. Under the Share Award Scheme, 1,811,500 new shares were issued during the month, and the number of new shares that may be issued at the end of the month is 2,187,250. The Company also repurchased 1,750,000 shares on April 30, 2024. Combined with all share movements during the month, the Company's ordinary shares increased/decreased by 61,500 shares. THE REPORT FINALLY CONFIRMS THAT ALL SECURITIES ISSUANCE HAS BEEN AUTHORIZED BY THE BOARD OF DIRECTORS AND COMPLIES WITH RELEVANT LEGAL REQUIREMENTS.
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTH CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 7 MAY 2024, REPORTING THE CHANGES IN THE COMPANY'S SHARES FOR THE YEAR ENDED 30 APRIL 2024. The report showed that the company's regulated/registered share capital remained at 20,000,000,000 shares with a face value of $0.000025 per share and a total share capital of $500,000, with no increase this month. In addition, the number of stock options outstanding at the end of last month was 39,250,950 in the Company's stock option program, which remained unchanged during the month. Under the Share Award Scheme, 1,811,500 new shares were issued during the month, and the number of new shares that may be issued at the end of the month is 2,187,250. The Company also repurchased 1,750,000 shares on April 30, 2024. Combined with all share movements during the month, the Company's ordinary shares increased/decreased by 61,500 shares. THE REPORT FINALLY CONFIRMS THAT ALL SECURITIES ISSUANCE HAS BEEN AUTHORIZED BY THE BOARD OF DIRECTORS AND COMPLIES WITH RELEVANT LEGAL REQUIREMENTS.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.